SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
February 10, 2004
(Date of earliest event reported)
ABIOMED, Inc.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
0-20584 |
|
04-2743260 |
||
|
(State or other jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
||
|
|
|
|
||||
|
22 Cherry Hill Drive, Danvers, Massachusetts |
|
01923 |
||||
|
(Address of principal executive offices) |
|
(Zip Code) |
||||
|
|
|
|
||||
|
(978) 777-5410 |
||||||
|
(Registrant’s telephone number, including area code) |
||||||
|
|
|
|
|
|
||
|
Not Applicable |
||||||
|
(Former name, former address and former fiscal year, if changed since last report) |
||||||
The Undersigned Registrant hereby amends its Form 8-K filed earlier on February 10, 2004, to correct an error in the press release attached as Exhbit 99.1. In particular, cash consumed by operating activities of $7.4 million occurred in the nine months ended December 31, 2003, a 42% decrease over the cash consumed by operations in the comparable nine months of the prior year. In our earlier filing we incorrectly indicated this cash was consumed over the three months ended December 31, 2003.
Item 7. Financial Statements and Exhibits.
(c) Exhibits
|
Exhibit Number |
|
Description |
|
99.1 |
|
Press release dated February 10, 2004 |
Item 12. Results of Operations and Financial Condition.
On February 10, 2004, ABIOMED, Inc. announced its financial results for its third fiscal quarter ending December 31, 2003. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
ABIOMED, Inc. |
||
|
|
|
||
|
|
|
||
|
|
By: |
/s/ Charles B. Haaser |
|
|
|
|
Charles B.
Haaser |
|
Date: February 10, 2004
3
Exhibit Index
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Press release dated February 10, 2004 |
4